Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening

IF 3.3 3区 医学 Q2 ONCOLOGY
Lye-Yeng Wong , Sania Choudhary , Ntemena Kapula , Margaret Lin , Irmina A. Elliott , Brandon A. Guenthart , Douglas Z. Liou , Leah M. Backhus , Mark F. Berry , Joseph B. Shrager , Natalie S. Lui
{"title":"Barriers to Completing Low Dose Computed Tomography Scan for Lung Cancer Screening","authors":"Lye-Yeng Wong ,&nbsp;Sania Choudhary ,&nbsp;Ntemena Kapula ,&nbsp;Margaret Lin ,&nbsp;Irmina A. Elliott ,&nbsp;Brandon A. Guenthart ,&nbsp;Douglas Z. Liou ,&nbsp;Leah M. Backhus ,&nbsp;Mark F. Berry ,&nbsp;Joseph B. Shrager ,&nbsp;Natalie S. Lui","doi":"10.1016/j.cllc.2024.04.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Annual low-dose computed tomography (LDCT) screening has been shown to reduce lung cancer mortality in high-risk individuals by detecting the disease at an earlier stage. This study aims to assess the barriers to completing LDCT in a cohort of patients who were determined eligible for lung cancer screening (LCS).</p></div><div><h3>Methods</h3><p>We performed a single institution, mixed methods, cross-sectional study of patients who had a LDCT ordered from July to December 2022. We then completed phone surveys with patients who did not complete LDCT to assess knowledge, attitude, and perceptions toward LCS.</p></div><div><h3>Results</h3><p>We identified 380 patients who met inclusion criteria, including 331 (87%) who completed LDCT and 49 (13%) who did not. Patients who completed a LDCT and those who did not were similar regarding age, sex, race, primary language, household income, body mass index, median pack years, and quit time. Positive predictors of LDCT completion were: meeting USPSTF guidelines (97.9% vs 81.6%), being married (58.3% vs 44.9%), former versus current smokers (55% vs 41.7%), personal history of emphysema (60.4% vs 42.9%), and family history of lung cancer (13.9% vs 4.1%) (all <em>P</em> &lt; .05). Of the patients who participated in the phone survey, only 7% of respondents thought they were high risk for developing lung cancer despite attending a shared decision-making visit and only 10% wanted to re-schedule their LDCT.</p></div><div><h3>Conclusion</h3><p>There exist barriers to completing LDCT even after patients are identified as eligible and complete a shared decision-making visit secondary to knowledge barriers, misperceptions, and patient disinterest.</p></div>","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":"25 5","pages":"Pages 424-430"},"PeriodicalIF":3.3000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1525730424000706/pdfft?md5=9857917bc79dd90e0582b4b357ae06cf&pid=1-s2.0-S1525730424000706-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525730424000706","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Annual low-dose computed tomography (LDCT) screening has been shown to reduce lung cancer mortality in high-risk individuals by detecting the disease at an earlier stage. This study aims to assess the barriers to completing LDCT in a cohort of patients who were determined eligible for lung cancer screening (LCS).

Methods

We performed a single institution, mixed methods, cross-sectional study of patients who had a LDCT ordered from July to December 2022. We then completed phone surveys with patients who did not complete LDCT to assess knowledge, attitude, and perceptions toward LCS.

Results

We identified 380 patients who met inclusion criteria, including 331 (87%) who completed LDCT and 49 (13%) who did not. Patients who completed a LDCT and those who did not were similar regarding age, sex, race, primary language, household income, body mass index, median pack years, and quit time. Positive predictors of LDCT completion were: meeting USPSTF guidelines (97.9% vs 81.6%), being married (58.3% vs 44.9%), former versus current smokers (55% vs 41.7%), personal history of emphysema (60.4% vs 42.9%), and family history of lung cancer (13.9% vs 4.1%) (all P < .05). Of the patients who participated in the phone survey, only 7% of respondents thought they were high risk for developing lung cancer despite attending a shared decision-making visit and only 10% wanted to re-schedule their LDCT.

Conclusion

There exist barriers to completing LDCT even after patients are identified as eligible and complete a shared decision-making visit secondary to knowledge barriers, misperceptions, and patient disinterest.

完成肺癌筛查低剂量计算机断层扫描的障碍
事实证明,每年一次的低剂量计算机断层扫描(LDCT)筛查能在早期发现肺癌,从而降低高危人群的肺癌死亡率。本研究旨在评估符合肺癌筛查(LCS)条件的一组患者完成 LDCT 的障碍。我们对 2022 年 7 月至 12 月期间接受 LDCT 检查的患者进行了一项单一机构、混合方法、横断面研究。然后,我们对未完成 LDCT 的患者进行了电话调查,以评估他们对 LCS 的认识、态度和看法。我们确定了 380 名符合纳入标准的患者,其中 331 人(87%)完成了 LDCT,49 人(13%)未完成。完成 LDCT 和未完成 LDCT 的患者在年龄、性别、种族、主要语言、家庭收入、体重指数、中位数包年和戒烟时间等方面相似。完成 LDCT 的积极预测因素包括:符合 USPSTF 指南(97.9% vs 81.6%)、已婚(58.3% vs 44.9%)、以前吸烟与现在吸烟(55% vs 41.7%)、个人肺气肿病史(60.4% vs 42.9%)和肺癌家族史(13.9% vs 4.1%)(均小于 0.05)。在参与电话调查的患者中,只有 7% 的受访者认为自己是肺癌高危人群,尽管他们参加了共同决策访视,只有 10% 的受访者希望重新安排 LDCT 的时间。由于知识障碍、误解和患者不感兴趣等原因,即使患者被确定为符合条件并完成共同决策访视后,仍存在完成 LDCT 的障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical lung cancer
Clinical lung cancer 医学-肿瘤学
CiteScore
7.00
自引率
2.80%
发文量
159
审稿时长
24 days
期刊介绍: Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信